Cargando…
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site
The insulin-like growth factor-1 receptor (IGF-1R) signaling pathway is critical for both normal mammary gland development and malignant transformation. It has been reported that the IGF-1 stimulates breast cancer cell proliferation and is upregulated in tumors with BRCA1/2 mutations. We report here...
Autores principales: | Kang, H J, Yi, Y W, Kim, H J, Hong, Y B, Seong, Y S, Bae, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388245/ https://www.ncbi.nlm.nih.gov/pubmed/22739988 http://dx.doi.org/10.1038/cddis.2012.78 |
Ejemplares similares
-
Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
por: Wang, Chuying, et al.
Publicado: (2018) -
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
por: Tung, Nadine, et al.
Publicado: (2010) -
Characterization of a negative transcriptional element in the BRCA1 promoter
por: MacDonald, Gwen, et al.
Publicado: (2007) -
Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017) -
BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
por: Wang, Li, et al.
Publicado: (2014)